Meetings / Mar 27, 2024 / Item 43

Item 43

approved

Mar 27, 2024

Description

Authorize to enter into a no-cost Confidential Disclosure Agreement with Asegua Therapeutics LLC to ensure confidentially of data for discussion, evaluation and negotiation related to Asegua’s product pricing and associated contingencies. Effective upon G&C approval through March 31, 2027.

Vote Record approved
Motion by Kenney, seconded by Warmington acted as follows
Joseph Kenney (R) yes
Cinde Warmington (D) yes
Janet Stevens (R) yes
Ted Gatsas (R) yes
Dave Wheeler (R) yes
Related Sub-Items (2)

Documents (2)

Item_43.pdf Open in new tab →
Item_43A.pdf (43A) Open in new tab →
← Back to Mar 27, 2024 meeting